Entering text into the input field will update the search result below

Momenta Pharmaceuticals beats by $0.03, beats on revenue

  • Momenta Pharmaceuticals (NASDAQ:MNTA): Q2 EPS of -$0.31 beats by $0.03.
  • Revenue of $26.43M (-41.1% Y/Y) beats by $3.53M.
  • Press Release

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
MNTA--
Momenta Pharmaceuticals, Inc.